On September 22nd, some investors asked 688621.SH: has the company's market position been further improved in the new year?
Yangguang Nuo and reply: Hello! Founded in 2009, the company is one of the earliest domestic CRO companies (Contract Research Organization, contract research organizations) to provide drug research and development services. The company has 36300 square meters of R & D laboratory, of which the laboratory area that has been put into use is 31700 square meters, and the laboratory area under construction is 4600 square meters. The company has international advanced instruments and equipment, as well as a group of scientific research backbone and talent team with rich experience in pharmaceutical research and development at home and abroad, which provides strong support for drug research and development. By the end of the reporting period, the company had 1185 employees, including 987 R & D personnel, accounting for 83.29% of the total staff; 817 R & D personnel with bachelor's degree or above, accounting for 82.78% of R & D personnel; and 180 R & D personnel with master's degree and doctorate, accounting for 18.24% of the R & D personnel. After years of continuous investment, integration and development, the company has built and established a comprehensive service technology platform integrating compound synthesis, compound activity screening, pharmaceutical research, pharmacodynamics evaluation, pharmacokinetics, clinical trials and biological analysis, and the company has gradually developed into a domestic preclinical and clinical comprehensive R & D service CRO with strong market competitiveness. Thank you!